VBVéronique Béréziat

Véronique Béréziat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Véronique Béréziat has a total of 105 co-authors. Here are the top co-authors by number of shared publications:

  • Claire Lagathu

    Inserm UMR_S938, Centre de Recherche Saint-Antoine, Institut Hospitalo-Universitaire de Cardio-Métabolisme et Nutrition (ICAN), Sorbonne Université, 75012 Paris, France

    10 shared publications
  • Jacqueline Capeau

    Inserm UMR_S938, CRSA, ICAN, Sorbonne Universite, Paris, France

    7 shared publications
  • Bruno Fève

    Service d’Endocrinologie, Hôpital Saint Antoine, INSERM UMR S 938, Centre de Recherche Saint-Antoine, Université Pierre et Marie Curie, Faculté de Médecine, Institut Hospitalo-Universitaire ICAN, Paris, France,

    5 shared publications
  • Jacqueline Capeau

    Sorbonne Université, Inserm UMR_S938, Institut Hospitalo-Universitaire de Cardio-Métabolisme et Nutrition (ICAN), Centre de Recherche Saint-Antoine-CRSA, Paris, 75012, France

    5 shared publications
  • Christine Bourgeois

    Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bicêtre

    4 shared publications
  • Michael Atlan

    Department of Plastic Surgery, Sorbonne University and inserm 1148, LVTS, Bichat Hospital, Paris, France

    4 shared publications

Latest Publications

  • Current antiretrovirals, hyperglycemia, and type 2 diabetes in people with HIV

    by Megan Farminer, Véronique Béréziat, Ghislaine Guillemain, Bruno Fève, Claire Lagathu, Jacqueline Capeau

  • Open Access

    C-C chemokine ligand 5 from women subcutaneous adipose tissue has a central role in vascular aging

    by Laura Le Pelletier, Kenza Ngono Ayissi, Jennifer Gorwood, Emilie Capel, Romain Morichon, Matthieu Mantecon, Martine Auclair, Rohia Alili, Christine Katlama, Lise Cuzin, et al.

    Aging is associated with adipose tissue alterations, oxidative stress, and fibrosis and the onset of cardiometabolic complications. While it has been shown that perivascular adipose tissue (PVAT) contributes to vascular damage, the involvement of subcutaneous adipose tissue (SCAT) - particularly through its secretory activity - in vascular aging remains poorly understood. Previously, we have demonstrated that human adipose-derived stromal cells (ASCs) from the SCAT of aged women display senescence and oxidative stress. We hypothesized that the ASC secretome contributes to the onset of endothelial dysfunction, an early stage of vascular aging. We prepared conditioned media from ASCs isolated from SCAT of healthy young (< 25y) or aged (> 60y) women. The ASCs secretome was analyzed and added on human coronary artery endothelial cells (HCAECs). Using clinical cohorts, we evaluated the expression of C-C-chemokine-ligand-5 (CCL5)/Regulated upon-Activation-Normally-T-expressed-and-secreted (RANTES) in adipose tissue of individuals with coronary heart disease. The secretome of aged-donor ASCs induced endothelial cell dysfunction in HCAEC, as evidenced by lower nitric oxide production, higher oxidative stress, senescence, and a pro-adherent phenotype. Aged-donor ASCs also favored the endothelial-to-mesenchymal transition, characterized by the higher expression of mesenchymal markers, a pro-migratory profile and angiogenesis. We showed that the higher secretion of CCL5/RANTES in the secretome of aged- vs. young-donor ASCs and was responsible for these effects. Accordingly, CCL5/RANTES expression in SCAT, but not in epicardial adipose tissue, was associated with blood pressure in patients with coronary heart diseases, thus confirming the important role of SCAT in the onset of cardiometabolic disorders. CCL5’s ability to induce endothelial cell dysfunction and senescence was confirmed using a recombinant CCL5 and a CCL5/RANTES neutralizing antibody. Furthermore, we demonstrated that the CCL5/RANTES receptor antagonist drug maraviroc prevented the deleterious impact of CCL5/RANTES in both HCAECs and human cohorts. Thus, CCL5/RANTES secreted from SCAT during aging could contribute to endothelial dysfunction by exerting both local and systemic effects. Our results highlighted the ability of the CCL5/RANTES released from aging SCAT and, specifically, from adipose stromal cells, to induce endothelial dysfunction and senescence - both of which are early steps in vascular aging - as well as a potential link between these phenomena and hypertension in particular. The online version contains supplementary material available at 10.1186/s12933-025-02815-4.

  • Open Access

    Human adipose stromal cells differentiate towards a tendon phenotype with adapted visco-elastic properties in a 3D-culture system

    by Maxime Hordé, Jonathan Fouchard, Luna Gomez Palacios, Xavier Laffray, Cédrine Blavet, Véronique Béréziat, Claire Lagathu, Ludovic Gaut, Delphine Duprez, Emmanuelle Havis

    Tendon cell differentiation relies on molecular and mechanical parameters that control the expression of tendon-associated transcription factors and extracellular matrix proteins. However, the minimal cues able to initiate tendon differentiation from progenitor cells remains unknown. We analysed the tendon differentiation program in human adipose stromal cells (hASCs) cultured in a minimal 3D system. We generated 3D-hASC constructs by embedding hASCs in a type-I collagen gel under a static uniaxial geometrical constraint with no additional molecular and mechanical cues, and assessed tendon-associated gene expression and mechanical properties for up to 3 weeks in culture. Analysis of tendon-associated genes revealed a molecular progression consistent with the acquisition of a tendon phenotype. The analysis of viscoelastic properties of 3D-hASC constructs by nano-indentation indicated a progressive increase in tissue stiffness up to 10 kPa, concomitant with a reduced stress relaxation indicative of solid-like mechanical properties. These changes in mechanical properties parallel the molecular change of matrix genes during the time of cultures. In summary, we have established that hASCs cultured in a minimal 3D-system progress into the tendon differentiation program associated with variations of mechanical properties.


  • Open Access

    Human adipose stromal cells differentiate towards a tendon phenotype with adapted visco-elastic properties in a 3D-culture system

    by Maxime Hordé, Jonathan Fouchard, Xavier Laffray, Cédrine Blavet, Véronique Béréziat, Claire Lagathu, Ludovic Gaut, Delphine Duprez, Emmanuelle Havis

    Tendons are composed of type I collagen fibrils and specialized extracellular matrix (ECM) proteins that are hierarchically organized to transmit forces from muscle to bone. Reliable and affordable models of human tendon constructs are requested to serve surgical treatment after tendon injury and in vitro pharmacological testing. Here, using human adipose stromal cells embedded in a 3D type-I collagen matrix and submitted to static uniaxial geometrical constraint, we generated human tendon constructs and assessed their mechanical properties and gene expression for up to 21 days in culture. The analysis of visco-elastic properties by nano-indentation indicated an increase in tissue stiffness (from about 1kPa at Day 0 to 10 kPa at Day 21), concomitant with a reduced percentage of stress relaxation, indicative of more solid-like mechanical properties. These changes in mechanical properties were associated with a reorganisation of ECM and the emergence of two cell populations, with one cell population organized as a ring in tissue periphery. In addition to the activation of the well-established tendon differentiation genetic program, assessed by the expression of SCX, MKX, TNMD and COL1A1, we validated the expression of a novel tendon marker, TM4SF1 and other components of the ECM such as COL6A3, COL14A1, DPT, DCN, POSTN and THBS2, which were previously identified in transcriptomic analyses of embryonic mouse limb tendons. In summary, this 3D culture system, which recapitulates most stages of tendon development, represent a potential route for human tendon regeneration.


  • Open Access

    Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques

    by Aude Mausoléo, Anaelle Olivo, Delphine Desjardins, Asier Sáez-Cirión, Aurélie Barrail-Tran, Véronique Avettand-Fenoel, Nicolas Noël, Claire Lagathu, Véronique Béréziat, Roger Le Grand, et al.

    During chronic SIV/HIV infection, adipose tissue (AT) is the target of both antiretroviral treatment (ART) and the virus. AT might subsequently contribute to the low-grade systemic inflammation observed in patients on ART. To evaluate the inflammatory profile of AT during chronic SIV/HIV infection, we assayed subcutaneous and visceral abdominal AT from non-infected (SIV−, control), ART-naïve SIV-infected (SIV+) and ART-controlled SIV-infected (SIV+ART+) cynomolgus macaques for the mRNA expression of genes coding for factors related to inflammation. Significant differences were observed only when comparing the SIV+ART+ group with the SIV+ and/or SIV− groups. ART-treated infection impacted the metabolic fraction (with elevated expression of PPARγ and CEBPα), the extracellular matrix (with elevated expression of COL1A2 and HIF-1α), and the inflammatory profile. Both pro- and anti-inflammatory signatures were detected in AT, with greater mRNA expression of anti-inflammatory markers (adiponectin and CD163) and markers associated with inflammation (TNF-α, Mx1, CCL5 and CX3CL1). There were no intergroup differences in other markers (IL-6 and MCP-1). In conclusion, we observed marked differences in the immune and metabolic profiles of AT in the context of an ART-treated, chronic SIV infection; these differences were related more to ART than to SIV infection per se.


  • Open Access

    Abnormal immune activation and fibrosis of epicardial adipose tissue in people living with HIV: results from the PIECVIH study

    by F Boccara, R Alili, C Poitou, C Lagathu, V Bereziat, L Le Pelletier, C Vigouroux, P Leprince, A Cohen, J Capeau

    Increased Epicardial Adipose Tissue (EAT) volume has been associated with increased risk of CAD in people living with HIV (PLWH). However, the underlying mechanisms remain unknown. We conducted the PIECVIH study to compare EAT properties in relation with CAD between PLWH and HIV-negative patients, all undergoing coronary artery bypass graft (CABG). The PIECVIH study is a cross sectional prospective study performed in a single center enrolling 11 ART-controlled PLWH and 11 matched (age ± 3 years and sex) HIV-negative patients requiring CABG. During surgery, EAT and thoracic subcutaneous fat samples were taken. Gene expression was analyzed in samples with sufficient mRNA quality (7 PLWH and 7 HIV− for subcutaneous fat, 9 PLWH and 8 HIV− samples for EAT). The expression of 30 genes, mainly related to inflammation, immune activation, fibrosis and adipokines, was evaluated and related to the expression of the reference gene 18S. The mean age of the cohort was 59.8 years (100% male). The cardiovascular risk profile was quite similar between both groups including 66% smokers, 64% hypercholesterolemia, 36% hypertriglyceridemia and 56% hypertension. However, HIV− subjects had a higher prevalence of diabetes (73% vs 18%, p=0.002) and a higher body mass index than HIV− (23,2 vs 27.5 kg/m2, p=0.017). The level of gene expression of all tested genes was not different between PLWH and HIV− subjects in subcutaneous fat. Conversely, in EAT, the relative expression of IL-6 and CCL2 was 3–5-fold higher in samples issued from PLWH than from HIV−: respectively 0.46 vs 0.13 (p=0.03) and 1.13 vs 0.24 (p=0.03). Moreover, only in EAT, and only in PLWH, the expression of the chemokines CCL2 and CCL5 and of the macrophage immune activation markers (CD68, CD163, CD206), was globally related to the expression of genes involved into fibrosis: collagen genes (COL1A1, COL3A1, COL3A1, COL6A2, COL6A3), TGFB, LOX (lysyl-oxidase) and ASAH1 (acid ceraminidase). Only in EAT and only in PLWH, the expression of IGF1 and CES (carboxylesterase 1), two genes associated with increased cardiovascular risk, was related to the expression of genes associated with immune activation, fibrosis and vascularization (VEGFA). Only in PLWH, the Gensini score, evaluating the severity of CAD, was associated with EAT expression of collagen 6 and of the CV risk factors IGF1 and CES. In very high CV risk subjects undergoing CABG, inflammation/immune activation of EAT was higher in PLWH as compared to controls. In EAT of PLWH, immune activation was strongly associated with fibrosis stressing for a dysfunctional EAT. Moreover, the severity of CAD, as addressed by the Gensini score, was associated with collagen 6 expression, a deleterious collagen in the context of EAT fibrosis. We propose that in PLWH, altered EAT immune profile and fibrosis could be responsible for reported accelerated CAD. Type of funding sources: Public grant(s) – National budget only. Main funding source(s): French Agency for Research on AIDS and Viral Hepatitis


  • Open Access

    Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes

    by Kenza Ngono Ayissi, Jennifer Gorwood, Laura Le Pelletier, Christine Bourgeois, Carine Beaupère, Martine Auclair, Roberta Foresti, Roberto Motterlini, Michael Atlan, Aurélie Barrail-Tran, et al.

    For people living with HIV, treatment with integrase-strand-transfer-inhibitors (INSTIs) can promote adipose tissue (AT) gain. We previously demonstrated that INSTIs can induce hypertrophy and fibrosis in AT of macaques and humans. By promoting energy expenditure, the emergence of beige adipocytes in white AT (beiging) could play an important role by limiting excess lipid storage and associated adipocyte dysfunction. We hypothesized that INSTIs could alter AT via beiging inhibition. Fibrosis and gene expression were measured in subcutaneous (SCAT) and visceral AT (VAT) from SIV-infected, dolutegravir-treated (SIVART) macaques. Beiging capacity was assessed in human adipose stromal cells (ASCs) undergoing differentiation and being exposed to dolutegravir, bictegravir, or raltegravir. Expression of beige markers, such as positive-regulatory-domain-containing-16 (PRDM16), were lower in AT of SIVART as compared to control macaques, whereas fibrosis-related genes were higher. Dolutegravir and bictegravir inhibited beige differentiation in ASCs, as shown by lower expression of beige markers and lower cell respiration. INSTIs also induced a hypertrophic insulin-resistant state associated with a pro-fibrotic phenotype. Our results indicate that adipocyte hypertrophy induced by INSTIs is involved via hypoxia (revealed by a greater hypoxia-inducible-factor-1-alpha gene expression) in fat fibrosis, beiging inhibition, and thus (via positive feedback), probably, further hypertrophy and associated insulin resistance.


  • Open Access

    Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction

    by Laura Le Pelletier, Matthieu Mantecon, Jennifer Gorwood, Martine Auclair, Roberta Foresti, Roberto Motterlini, Mireille Laforge, Michael Atlan, Bruno Fève, Jacqueline Capeau, et al.

    Aging is associated with central fat redistribution and insulin resistance. To identify age-related adipose features, we evaluated the senescence and adipogenic potential of adipose-derived stromal cells (ASCs) from abdominal subcutaneous fat obtained from healthy normal-weight young (60 years). Increased cell passages of young-donor ASCs (in vitro aging) resulted in senescence but not oxidative stress. ASC-derived adipocytes presented impaired adipogenesis but no early mitochondrial dysfunction. Conversely, aged-donor ASCs at early passages displayed oxidative stress and mild senescence. ASC-derived adipocytes exhibited oxidative stress, and early mitochondrial dysfunction but adipogenesis was preserved. In vitro aging of aged-donor ASCs resulted in further increased senescence, mitochondrial dysfunction, oxidative stress, and severe adipocyte dysfunction. When in vitro aged young-donor ASCs were treated with metformin, no alteration was alleviated. Conversely, metformin treatment of aged-donor ASCs decreased oxidative stress and mitochondrial dysfunction resulting in decreased senescence. Metformin’s prevention of oxidative stress and of the resulting senescence improved the cells’ adipogenic capacity and insulin sensitivity. This effect was mediated by the activation of AMP-activated protein kinase as revealed by its specific inhibition and activation. Overall, aging ASC-derived adipocytes presented impaired adipogenesis and insulin sensitivity. Targeting stress-induced senescence of ASCs with metformin may improve age-related adipose tissue dysfunction.


  • Open Access

    Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment

    by Christine Bourgeois, Jennifer Gorwood, Anaelle Olivo, Laura Le Pelletier, Jacqueline Capeau, Olivier Lambotte, Véronique Béréziat, Claire Lagathu

    White adipose tissue (AT) contributes significantly to inflammation – especially in the context of obesity. Several of AT’s intrinsic features favor its key role in local and systemic inflammation: (i) large distribution throughout the body, (ii) major endocrine activity, and (iii) presence of metabolic and immune cells in close proximity. In obesity, the concomitant pro-inflammatory signals produced by immune cells, adipocytes and adipose stem cells help to drive local inflammation in a vicious circle. Although the secretion of adipokines by AT is a prime contributor to systemic inflammation, the lipotoxicity associated with AT dysfunction might also be involved and could affect distant organs. In HIV-infected patients, the AT is targeted by both HIV infection and antiretroviral therapy (ART). During the primary phase of infection, the virus targets AT directly (by infecting AT CD4 T cells) and indirectly (via viral protein release, inflammatory signals, and gut disruption). The initiation of ART drastically changes the picture: ART reduces viral load, restores (at least partially) the CD4 T cell count, and dampens inflammatory processes on the whole-body level but also within the AT. However, ART induces AT dysfunction and metabolic side effects, which are highly dependent on the individual molecules and the combination used. First generation thymidine reverse transcriptase inhibitors predominantly target mitochondrial DNA and induce oxidative stress and adipocyte death. Protease inhibitors predominantly affect metabolic pathways (affecting adipogenesis and adipocyte homeostasis) resulting in insulin resistance. Recently marketed integrase strand transfer inhibitors induce both adipocyte adipogenesis, hypertrophy and fibrosis. It is challenging to distinguish between the respective effects of viral persistence, persistent immune defects and ART toxicity on the inflammatory profile present in ART-controlled HIV-infected patients. The host metabolic status, the size of the pre-established viral reservoir, the quality of the immune restoration, and the natural ageing with associated comorbidities may mitigate and/or reinforce the contribution of antiretrovirals (ARVs) toxicity to the development of low-grade inflammation in HIV-infected patients. Protecting AT functions appears highly relevant in ART-controlled HIV-infected patients. It requires lifestyle habits improvement in the absence of effective anti-inflammatory treatment. Besides, reducing ART toxicities remains a crucial therapeutic goal.


  • Open Access

    Metformin alleviates aging-associated cellular senescence of human adipose stem cells and derived adipocytes

    by Matthieu Mantecon, Laura Le Pelletier, Jennifer Gorwood, Martine Auclair, Michael Atlan, Bruno Fève, Jacqueline Capeau, Claire Lagathu, Véronique Béréziat

    SUMMARY: Aging is associated with central fat redistribution, and insulin resistance. To identify age-related adipose features, we evaluated the senescence and adipogenic potential of adipose-derived-stemcells (ASCs) from abdominal subcutaneous fat obtained from healthy normal-weight young (60y). Aged-donor ASCs showed more intense features of aging (senescence, mitochondrial dysfunction, and oxidative stress) than young-donor ASCs. Oxidative stress and mitochondrial dysfunction occurred earlier in adipocytes derived from aged-donor than from young-donor ASCs, leading to insulin resistance and impaired adipogenesis. When aged-donor ASCs were treated with metformin, senescence, oxidative stress and mitochondrial dysfunction returned to the levels observed in young-donor ASCs. Furthermore, metformin’s prevention of senescence and dysfunction during ASC proliferation restored the cells’ adipogenic capacity and insulin sensitivity. This effect was mediated by the activation of AMP-activated-protein-kinase. We show here that targeting senescent ASCs from aged women with metformin may alleviate age-related dysfunction, insulin resistance, and impaired adipogenesis.